K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · ILMN
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-05-07 | ILMN | ILLUMINA INC. | THORN RUN PARTNERS | $0 | FY27 House LHHS & Senate Defense Appropriations in relation to proteomics research. |
| 2026-04-20 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $320K | P.L. 118-42 (H.R. 4366 (118th Congress)): Consolidated Appropriations Act, 2024; all provisions Discussions related to National Institutes of Health (NIH) funding Discussions related to U.S. government disease surveillance programs H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions General issues related to trade |
| 2026-04-20 | ILMN | ILLUMINA INC. | MILLER STRATEGIES, LLC | $80K | General issues related to trade. |
| 2026-04-20 | ILMN | ILLUMINA INC. | TODD STRATEGY GROUP | $80K | General discussions related to FDA regulation of diagnostics. General discussions related to Medicare reimbursement for diagnostic tests. General trade issues. |
| 2026-04-20 | ILMN | ILLUMINA INC. | AVENUE SOLUTIONS | $60K | H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence General trade issues |
| 2026-04-20 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | $19K | Issues related to health care diagnostics NIH Funding |
| 2026-04-19 | ILMN | ILLUMINATE USA | FORBES-TATE | $60K | Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and impl |
| 2026-03-12 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | $19K | issues related to the National Defense Authorization Act for FY 2025 issues related to health care diagnostics |
| 2026-03-09 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL AND ASSOCIATES | $19K | issues related to the National Defense Authorization Act for FY 2025 issues related to health care diagnostics |
| 2026-02-11 | ILMN | ILLUMINATE USA | FORBES-TATE | $0 | Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and impl |
| 2026-01-20 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $330K | |
| 2026-01-20 | ILMN | ILLUMINA INC. | MILLER STRATEGIES, LLC | $80K | General issues related to trade. |
| 2026-01-20 | ILMN | ILLUMINA INC. | AVENUE SOLUTIONS | $60K | H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to NIH grant funding for public health; Issues related to genomic sequencing |
| 2026-01-20 | ILMN | ILLUMINA INC. | TODD STRATEGY GROUP | $60K | General discussions related to FDA regulation of diagnostics. General discussions related to Medicare reimbursement for diagnostic tests. General trade issues. |
| 2026-01-18 | ILMN | ILLUMINATE USA LLC | HOLLAND & KNIGHT LLP | $120K | Solar panel manufacturing. Solar panel manufacturing. 45X- Advanced Manufacturing Production Credit. |
| 2026-01-16 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL AND ASSOCIATES | $19K | Issues related to health care diagnostics NIH Funding |
| 2026-01-13 | ILMN | ACTUM OBO ILLUMINA INC. | S-3 GROUP | $50K | Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies. Issues and legislation related to tax reform and corporate tax policy General discussion and monitoring of U.S. trade policy |
| 2025-10-20 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $380K | H.R. 1: One Big Beautiful Bill Act; provisions related to National Institutes of Health and Medicare reimbursement H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing General discussions related to tariffs and trade negotiations |
| 2025-10-20 | ILMN | ILLUMINA INC. | MILLER STRATEGIES, LLC | $110K | General issues related to trade. |
| 2025-10-20 | ILMN | ILLUMINA INC. | AVENUE SOLUTIONS | $60K | H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to NIH grant funding for public health; Issues related to genomic sequencing |
| 2025-10-20 | ILMN | ILLUMINA INC. | TODD STRATEGY GROUP | $60K | General discussions related to the Food and Drug Administration's regulation of diagnostics. General health care procurement policy issues. |
| 2025-10-20 | ILMN | ACTUM OBO ILLUMINA INC. | S-3 GROUP | $50K | Issues and legislation related to tax reform and corporate tax policy General discussion and monitoring of U.S. trade policy Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies. |
| 2025-10-20 | ILMN | ILLUMINA | FARRAGUT PARTNERS LLP | $50K | General healthcare issues and competition issues |
| 2025-10-20 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL AND ASSOCIATES | $19K | Issues related to health care diagnostics NIH Funding |
| 2025-10-11 | ILMN | ILLUMINATE USA LLC | HOLLAND & KNIGHT LLP | $120K | Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Antidumping and Countervailing Duties (AD/CVD) related to solar imports. |
| 2025-09-25 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL AND ASSOCIATES | $19K | issues related to the National Defense Authorization Act for FY 2025 issues related to health care diagnostics |
| 2025-09-22 | ILMN | ILLUMINA | FARRAGUT PARTNERS LLP | $0 | General healthcare issues and competition issues |
| 2025-07-21 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $410K | H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing Discussions related to Artificial Intelligence Discussions related to permanent Research and Development (R&D) expensing Discussions related to Tariffs |
| 2025-07-21 | ILMN | ILLUMINA INC. | AVENUE SOLUTIONS | $60K | H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to NIH grant funding for public health; Issues related to genomic sequencing |
| 2025-07-21 | ILMN | ILLUMINA | FARRAGUT PARTNERS LLP | $50K | General healthcare issues and competition issues |
| 2025-07-21 | ILMN | ILLUMINA INC. | MILLER STRATEGIES, LLC | $40K | General issues related to trade. |
| 2025-07-19 | ILMN | ILLUMINA INC. | TODD STRATEGY GROUP | $60K | General discussions related to the Food and Drug Administration's regulation of diagnostics. General health care procurement policy issues. |
| 2025-07-18 | ILMN | ACTUM OBO ILLUMINA INC. | S-3 GROUP | $50K | Issues and legislation related to tax reform and corporate tax policy General discussion and monitoring of U.S. trade policy Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies. |
| 2025-07-18 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL AND ASSOCIATES | $19K | Issues related to health care diagnostics NIH Funding |
| 2025-07-13 | ILMN | ILLUMINATE USA LLC | HOLLAND & KNIGHT LLP | $120K | Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Antidumping and Countervailing Duties (AD/CVD) related to solar imports. |
| 2025-07-10 | ILMN | ILLUMINA INC. | MILLER STRATEGIES, LLC | $0 | General issues related to trade. |
| 2025-05-14 | ILMN | ACTUM OBO ILLUMINA INC. | S-3 GROUP | $50K | Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies. Issues and legislation related to tax reform and corporate tax policy General discussion and monitoring of U.S. trade policy |
| 2025-05-08 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $620K | H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions Discussions related to National Institutes of Health funding Discussions related to Laboratory Developed Tests (LDTs) regulation Discussions related to Disease Detection |
| 2025-04-21 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $630K | H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions Discussions related to National Institutes of Health funding Discussions related to Laboratory Developed Tests (LDTs) regulation Discussions related to Disease Detection |
| 2025-04-21 | ILMN | ILLUMINA INC. | TODD STRATEGY GROUP | $60K | General Discussions related to the Food and Drug Administration's regulation of diagnostics. General health care procurement policy issues. |
| 2025-04-21 | ILMN | ILLUMINA INC. | AVENUE SOLUTIONS | $60K | H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4) - issues related to NIH funding; H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act |
| 2025-04-21 | ILMN | ILLUMINA | FARRAGUT PARTNERS LLP | $50K | General healthcare issues and competition issues |
| 2025-04-21 | ILMN | ACTUM OBO ILLUMINA INC. | S-3 GROUP | $50K | Issues and legislation related to US National security, genomic security and National Defense Authorization Act |
| 2025-04-16 | ILMN | ILLUMINA INC. | JEFFREY J. KIMBELL AND ASSOCIATES | $19K | Issues related to health care diagnostics NIH Funding |
| 2025-04-12 | ILMN | ILLUMINATE USA LLC | HOLLAND & KNIGHT LLP | $120K | Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. AD/CVD related to solar imports. |
| 2025-01-21 | ILMN | ILLUMINA INC. | ILLUMINA, INC. | $400K | H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization General discussions related to Cures 2.0 H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security |
| 2025-01-21 | ILMN | ILLUMINA INC. | AVENUE SOLUTIONS | $60K | Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025; H.R. 10545, American Relief Act, 2025 |
| 2025-01-21 | ILMN | ILLUMINA | FARRAGUT PARTNERS LLP | $50K | General healthcare issues and competition issues |
| 2025-01-20 | ILMN | ACTUM OBO ILLUMINA INC. | S-3 GROUP | $50K | Issues and legislation related to US National security and genomic security |
| 2025-01-19 | ILMN | ILLUMINATE USA LLC | HOLLAND & KNIGHT LLP | $120K | S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022. |